Related Experiment Video
Updated: May 23, 2025

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
Published on: September 7, 2017
Methyltransferase-Like 3-Mediated N6-Methyladenosine Modification on RNAs: A Novel Perspective for the Pathogenesis
Dongqiong Xiao1, Deshuang Zhang1,2, Yi Qu1
1Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Ministry of Education), NHC Key Laboratory of Chronobiology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
Abstract:
Osteoarthritis, osteoporosis, and osteosarcoma are prevalent osseous pathologies associated with the aberrant functionality of chondrocytes, osteoclasts, and osteoblasts, respectively. These conditions frequently exhibit therapeutic resistance and possess a high mortality risk, thus representing substantial health threats. To mitigate these concerns, it is imperative to investigate novel mechanistic insights. Methyltransferase-like 3 (METTL3) is pivotal in these disorders by modulating gene expression via N6-methyladenosine (m6A) modifications on RNA, thereby impacting cellular processes. Although considerable research has elucidated METTL3's involvement in these diseases, a systematic review is essential to summarise these findings and evaluate METTL3's significance. This review endeavours to aggregate and examine contemporary studies to elucidate METTL3's role in bone pathologies and its clinical implications. We propose that METTL3 constitutes a risk gene in these conditions by mediating m6A modifications on both mRNAs and non-coding RNAs, suggesting that METTL3 may serve as a critical diagnostic biomarker and therapeutic target. In conclusion, this review provides an extensive analysis of METTL3 and its correlation with osteoarthritis, osteoporosis, and osteosarcoma, offering valuable perspectives on extant research and serving as a valuable reference for researchers engaged in both basic and translational studies.
Insights
Methyltransferase-like 3 (METTL3) impacts gene expression in bone diseases like osteoarthritis and osteoporosis. This review highlights METTL3 as a potential diagnostic biomarker and therapeutic target for these prevalent conditions.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Osteoarthritis, osteoporosis, and osteosarcoma are significant bone pathologies with high mortality and therapeutic resistance.
- Aberrant chondrocyte, osteoclast, and osteoblast function underlies these prevalent osseous conditions.
- Investigating novel mechanistic insights is crucial for mitigating these health threats.
Purpose of the Study:
- To systematically review and summarize current research on the role of Methyltransferase-like 3 (METTL3) in bone pathologies.
- To evaluate the clinical significance and implications of METTL3 in osteoarthritis, osteoporosis, and osteosarcoma.
- To elucidate METTL3's function in mediating N6-methyladenosine (m6A) modifications and its impact on cellular processes in bone diseases.
Main Methods:
- Systematic review and aggregation of contemporary studies.
- Analysis of existing literature on METTL3's involvement in osteoarthritis, osteoporosis, and osteosarcoma.
- Examination of METTL3's role in RNA m6A modifications and gene expression regulation.
Main Results:
- METTL3 plays a pivotal role in the pathogenesis of osteoarthritis, osteoporosis, and osteosarcoma.
- METTL3 mediates m6A modifications on both messenger RNAs (mRNAs) and non-coding RNAs, influencing cellular functions.
- Evidence suggests METTL3 acts as a risk gene in these bone conditions.
Conclusions:
- METTL3 is significantly correlated with osteoarthritis, osteoporosis, and osteosarcoma.
- METTL3 holds potential as a critical diagnostic biomarker for these bone pathologies.
- Targeting METTL3 may offer a novel therapeutic strategy for managing bone diseases.
Related Concept Videos
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Master Transcription Regulators
Epigenetic Regulation
X-chromosome...
Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...

